Chest
Volume 131, Issue 6, June 2007, Pages 1800-1805
Journal home page for Chest

ORIGINAL RESEARCH
INTERVENTIONAL PULMONOLOGY
Electromagnetic Navigation Diagnostic Bronchoscopy in Peripheral Lung Lesions

https://doi.org/10.1378/chest.06-3016Get rights and content

Background

Electromagnetic navigation bronchoscopy (ENB) with biopsy under fluoroscopic guidance has enhanced the yield of flexible bronchoscopy in the diagnosis of peripheral lung lesions. However, the accuracy of ENB navigation suggests that the addition of fluoroscopy is redundant.

Objectives

Data were prospectively collected to determine the yield of ENB without fluoroscopy in the diagnosis of peripheral lung lesions.

Method

ENB was performed via flexible bronchoscopy (superDimension/Bronchus system; superDimension Inc; Plymouth, MN). Biopsy specimens were obtained through the extended working channel after navigation. Fluoroscopy was not utilized, but post-transbronchial biopsy chest radiographs were obtained to exclude pneumothorax. The primary end point was diagnostic yield, and the secondary end points were navigation accuracy, procedure duration, and safety. Analysis by lobar distribution was also performed to assess performance in different lobes of the lung.

Results

Ninety-two peripheral lung lesions were biopsied in the 89 subjects. The diagnostic yield of ENB was 67%, which was independent of lesion size. Total procedure time ranged from 16.3 to 45.0 min (mean [± SD] procedure time, 26.9 ± 6.5 min). The mean navigation error was 9 ± 6 mm (range, 1 to 31 mm). There were two incidences of pneumothorax for which no intervention was required. When analyzed by lobar distribution, there was a trend toward a higher ENB yield in diagnosing lesions in the right middle lobe (88%).

Conclusions

ENB can be used as a stand-alone bronchoscopic technique without compromising diagnostic yield or increasing the risk of pneumothorax. This may result in sizable timesaving and avoids radiation exposure.

Section snippets

Materials and Methods

Eighty-nine patients underwent ENB at our two centers between February 2005 and August 2006. Inclusion criteria were subjects above the age of 18 years, who signed informed consent forms and were candidates for elective bronchoscopy. They all had evidence of peripheral lung lesions or solitary pulmonary nodules with no evidence of endobronchial pathology. Pregnant patients and those with implantable pacemakers or defibrillators were excluded. The institutional review boards of both of the

Results

Ninety-two peripheral lung lesions were biopsied in the 89 subjects, of whom 39 (44%) were female. The mean age was 67 ± 12 years (age range, 29 to 95 years). The mean size of lesions was 24 ± 8 mm (range, 10 to 58 mm); the mean number of forceps biopsies performed was 5 ± 1 (range, 0 to 11). A single patient had no forceps biopsies because the navigation error was 31 mm despite multiple attempts. This was attributed to the possible absence of a bronchus leading to the lesion. The bronchial

Discussion

In this largest series to date, we have shown that ENB can be used as an independent bronchoscopic technique without the need for fluoroscopy when compared with other available studies. There was no compromise in the diagnostic yield and no increased risk of pneumothorax. This yield was attributable to the small registration error (< 5 mm) and navigation error (< 10 mm) that occurred. Our pneumothorax rate (2 of 89 patients; 2%) compares favorably with those of preceding studies,35 in which the

ACKNOWLEDGMENT

Dr. Roger Davis from Department of Medicine, Beth Israel Deaconess Medical Center (Boston, MA) assisted with the statistical analysis. Robert Garland from Interventional Pulmonology, Beth Israel Deaconess Medical Center (Boston, MA) assisted with data collection.

Cited by (276)

View all citing articles on Scopus

A portion of these data has been accepted as an abstract for the 2007 American Thoracic Society International Conference.

The locatable sensor probes at both Thoraxklinik and Beth Israel Deaconess Medical Center were provided free of charge by superDimension/Bronchus. superDimension/Bronchus has supported CME courses at the Thoraxklinik Heidelberg and Harvard University through unrestricted educational grants. Dr. Ernst was a member of the Scientific Advisory Board of superDimension/Bronchus and had been reimbursed for time and travel expenses related to that function. Dr. Ernst also had stock options, which have been returned in the past. Dr. Ernst was not involved in the consenting process of patients. Drs. Eberhardt, Anantham, Herth, and Feller-Kopman have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.

View full text